EHC Launches Survey on Rare Bleeding Disorders and BDUC Needs
The European Haemophilia Consortium (EHC) shared an encouraging post on X:
”Help shape the future of care for people with Extremely Rare bleeding disorders and BDUC across Europe! The EHC Survey is open—share your experience so no voice is left behind!”
To take the survey, follow the link.
The European Haemophilia Consortium is collecting insights from the community to help The Community! Bleeding Disorders take the spotlight.
EHC has launched a pan-European survey to better understand the needs of individuals living with extremely rare bleeding disorders (ERBDs) and bleeding disorders of unknown cause (BDUC).
Aimed at gathering direct input from patients across National Member Organisations (NMOs), the survey seeks to ensure that no voice is left unheard.
Insights will inform future advocacy, care strategies, and research priorities—help shape the future of care by sharing your experience today.
Never miss the important in the World of Bleeding Disorders, read Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis